TY - JOUR
T1 - The effects of individually tailored nurse navigation for patients with newly diagnosed breast cancer
T2 - a randomized pilot study
AU - Mertz, Birgitte Goldschmidt
AU - Dunn-Henriksen, Anne Katrine
AU - Kroman, Niels
AU - Johansen, Christoffer
AU - Andersen, Kenneth Geving
AU - Andersson, Michael
AU - Mathiesen, Ulla Breitenstein
AU - Vibe-Petersen, Jette
AU - Dalton, Susanne Oksbjerg
AU - Envold Bidstrup, Pernille
PY - 2017/12/2
Y1 - 2017/12/2
N2 - Aim: Our aim was to determine the feasibility and effectiveness of an individual, nurse-navigator intervention for relieving distress, anxiety, depression and health-related quality of life in women who have been treated for breast cancer (BC) and are experiencing moderate-to-severe psychological and physical symptoms. Methods: Fifty women with newly diagnosed BC who reported distress (score ≥7 on distress thermometer) before surgery were included consecutively in a pilot study and randomized 1:1 to the intervention or the control group. The intervention comprised repeated screening with patient reported outcome measures and nurse navigation. A total of 66 women who were not distressed (score <7) were followed longitudinally as an observational group. Participants filled in four questionnaires, at baseline, after 6 months and 12 months. The primary outcome was psychological distress and the secondary outcomes were anxiety, depression, health-related quality of life and feasibility of the intervention. Results: Women in the intervention group reported significantly greater satisfaction with treatment and rehabilitation and lower levels of distress (mean 2.7 vs. 5.1, p<.01), anxiety (mean 5.1 vs. 7.8, p =.02) and depression (mean 2.2 vs. 4.4, p =.04) after 12 months compared to the control group. No significant effects were seen on health-related quality of life. Conclusions: The study shows promising feasibility of the individually tailored nurse-navigation intervention and while no significant effects were observed after 6 months, we did find statistically significant effects on distress, anxiety and depression 12 months after diagnosis. Our results will assist in developing rehabilitation to the most vulnerable patients.
AB - Aim: Our aim was to determine the feasibility and effectiveness of an individual, nurse-navigator intervention for relieving distress, anxiety, depression and health-related quality of life in women who have been treated for breast cancer (BC) and are experiencing moderate-to-severe psychological and physical symptoms. Methods: Fifty women with newly diagnosed BC who reported distress (score ≥7 on distress thermometer) before surgery were included consecutively in a pilot study and randomized 1:1 to the intervention or the control group. The intervention comprised repeated screening with patient reported outcome measures and nurse navigation. A total of 66 women who were not distressed (score <7) were followed longitudinally as an observational group. Participants filled in four questionnaires, at baseline, after 6 months and 12 months. The primary outcome was psychological distress and the secondary outcomes were anxiety, depression, health-related quality of life and feasibility of the intervention. Results: Women in the intervention group reported significantly greater satisfaction with treatment and rehabilitation and lower levels of distress (mean 2.7 vs. 5.1, p<.01), anxiety (mean 5.1 vs. 7.8, p =.02) and depression (mean 2.2 vs. 4.4, p =.04) after 12 months compared to the control group. No significant effects were seen on health-related quality of life. Conclusions: The study shows promising feasibility of the individually tailored nurse-navigation intervention and while no significant effects were observed after 6 months, we did find statistically significant effects on distress, anxiety and depression 12 months after diagnosis. Our results will assist in developing rehabilitation to the most vulnerable patients.
KW - Journal Article
U2 - 10.1080/0284186x.2017.1358462
DO - 10.1080/0284186x.2017.1358462
M3 - Journal article
C2 - 28758822
SN - 0284-186X
VL - 56
SP - 1682
EP - 1689
JO - Acta Oncologica
JF - Acta Oncologica
IS - 12
ER -
